Nov 9, 2021 | Press Releases
Financial results to be released after market close; Conference call to be conducted at 4:30 pm ETSARASOTA, Fla., Nov. 9, 2021 — INVO Bioscience, Inc. (NASDAQ: INVO), a medical device company focused on commercializing the world’s only in vivo Culture...
Nov 8, 2021 | Press Releases
SARASOTA, Fla., Nov. 8, 2021 — INVO Bioscience, Inc. (“INVO” or the “Company”) (NASDAQ: INVO), a medical device company focused on commercializing the world’s only in vivo culture system (IVC), today announced it will regain full...
Oct 20, 2021 | Press Releases
SARASOTA, Fla. and BALTIMORE, Oct. 20, 2021 — INVO Bioscience, Inc. (NASDAQ: INVO), a medical device company focused on commercializing the world’s only in vivo Intravaginal Culture System (IVC), INVOcell®, an effective and affordable treatment for...
Oct 14, 2021 | Press Releases
Positib Fertility, an INVO Center, becomes first international JV-owned clinic focused on providing INVOcell to assist the underserved patients in need of advanced fertility careSARASOTA, Fla. and MONTERREY, Mexico, Oct. 14, 2021 — INVO Bioscience, Inc. (NASDAQ:...
Oct 1, 2021 | Press Releases
SARASOTA, Fla., Oct. 1, 2021 — INVO Bioscience, Inc. (NASDAQ: INVO), a medical device company focused on commercializing the world’s only in vivo culture system (IVC), INVOcell®, today announced that it has entered into definitive agreements with...
Sep 9, 2021 | Press Releases
Provides platform to leverage the existing INVOcell product registration in Canada and ongoing work with leading embryologist, Ric Ross, to establish INVO Centers and enhance distribution into existing fertility clinicsSARASOTA, Fla., Sept. 9, 2021 — INVO...
